Zdrowie i gospodarka · 24/11/2015
FDA Approves New Animal Drug for Genetically Engineered Salmon
The US Food and Drug Administration has amended its animal drug regulations to approve a new application by AquaBounty Technologies, Inc. for a genetically engineered Atlantic salmon that uses a recombinant DNA gene construct.
Source: Federal Register — Food and Drug AdministrationOpen original release →